The share Buy Back has generated $5m in value for existing shareholders because of an approximate discount to NTA throughout the year of around $0.50/share. Well done to management for this smart move.
This little industrial property developer continues to deliver and once interest rates start to go down the valuation metrics will improve.
- Forums
- ASX - By Stock
- GDF
- Ann: GARDA Annual Results Presentation
Ann: GARDA Annual Results Presentation, page-2
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GDF (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
0.010(0.87%) |
Mkt cap ! $253.7M |
Open | High | Low | Value | Volume |
$1.16 | $1.18 | $1.15 | $64.40K | 55.75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 68663 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 4 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 68663 | 1.150 |
2 | 24318 | 1.140 |
1 | 1399 | 1.110 |
1 | 32500 | 1.105 |
2 | 3720 | 1.100 |
Price($) | Vol. | No. |
---|---|---|
1.160 | 4 | 1 |
1.175 | 16773 | 2 |
1.180 | 33978 | 2 |
1.190 | 1000 | 1 |
1.195 | 13818 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
GDF (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online